Met Life Investment Management, LLC Veracyte, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 46,945 shares of VCYT stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,945
Previous 43,867 7.02%
Holding current value
$1.44 Million
Previous $1.49 Million 24.6%
% of portfolio
0.01%
Previous 0.01%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$31.92 - $44.4 $98,249 - $136,663
3,078 Added 7.02%
46,945 $1.86 Million
Q2 2024

Aug 13, 2024
BUY
$18.86 - $23.55 $100,674 - $125,709
5,338 Added 13.85%
43,867 $950,000
Q1 2024

May 14, 2024
BUY
$21.0 - $29.1 $809,109 - $1.12 Million
38,529 New
38,529 $853,000
Q3 2023

May 09, 2024
BUY
$22.33 - $29.92 $12,929 - $17,323
579 Added 1.53%
38,529 $860,000
Q2 2023

Apr 29, 2024
BUY
$20.96 - $26.99 $807,567 - $1.04 Million
38,529 New
38,529 $981,000
Q2 2023

Aug 10, 2023
BUY
$20.96 - $26.99 $807,567 - $1.04 Million
38,529 New
38,529 $981,000
Q1 2023

May 09, 2024
BUY
$20.58 - $27.89 $781,010 - $1.06 Million
37,950 New
37,950 $846 Million
Q4 2022

Jun 14, 2023
BUY
$15.31 - $29.94 $581,014 - $1.14 Million
37,950 New
37,950 $900,000
Q3 2022

Jun 14, 2023
BUY
$16.58 - $27.9 $629,210 - $1.06 Million
37,950 New
37,950 $629,000
Q2 2022

Jun 20, 2023
BUY
$15.45 - $29.52 $586,327 - $1.12 Million
37,950 New
37,950 $755,000
Q1 2022

May 10, 2024
BUY
$21.94 - $42.51 $832,623 - $1.61 Million
37,950 New
37,950 $1.05 Million
Q1 2022

Jun 20, 2023
BUY
$21.94 - $42.51 $832,623 - $1.61 Million
37,950 New
37,950 $1.05 Million
Q1 2022

Mar 22, 2023
BUY
$21.94 - $42.51 $293,842 - $569,336
13,393 Added 54.54%
37,950 $1.05 Million
Q1 2022

May 12, 2022
BUY
$21.94 - $42.51 $293,842 - $569,336
13,393 Added 54.54%
37,950 $1.05 Million
Q4 2021

Jun 21, 2023
BUY
$36.09 - $53.79 $886,262 - $1.32 Million
24,557 New
24,557 $1.01 Million
Q3 2021

Jun 21, 2023
BUY
$35.62 - $52.97 $874,720 - $1.3 Million
24,557 New
24,557 $1.14 Million
Q1 2021

May 17, 2024
SELL
$44.47 - $81.38 $621,334 - $1.14 Million
-13,972 Reduced 36.26%
24,557 $1.32 Million
Q1 2021

Jun 26, 2023
BUY
$44.47 - $81.38 $1.09 Million - $2 Million
24,557 New
24,557 $1.32 Billion
Q1 2021

Mar 22, 2023
BUY
$44.47 - $81.38 $8,049 - $14,729
181 Added 0.74%
24,557 $1.32 Million
Q1 2021

May 14, 2021
BUY
$44.47 - $81.38 $8,049 - $14,729
181 Added 0.74%
24,557 $1.32 Million
Q4 2020

Jun 22, 2023
BUY
$32.49 - $61.88 $791,976 - $1.51 Million
24,376 New
24,376 $1.19 Million
Q3 2020

May 24, 2024
BUY
$26.73 - $35.67 $78,318 - $104,513
2,930 Added 13.66%
24,376 $792 Million
Q3 2020

Jun 26, 2023
BUY
$26.73 - $35.67 $651,570 - $869,491
24,376 New
24,376 $791,000
Q3 2020

Mar 22, 2023
BUY
$26.73 - $35.67 $78,318 - $104,513
2,930 Added 13.66%
24,376 $791,000
Q3 2020

Nov 13, 2020
BUY
$26.73 - $35.67 $78,318 - $104,513
2,930 Added 13.66%
24,376 $792,000
Q2 2020

May 24, 2024
SELL
$19.49 - $28.11 $332,947 - $480,203
-17,083 Reduced 44.34%
21,446 $555 Million
Q2 2020

Jun 26, 2023
BUY
$19.49 - $28.11 $417,982 - $602,847
21,446 New
21,446 $555,000
Q1 2020

Jul 12, 2023
BUY
$16.13 - $30.17 $345,923 - $647,025
21,446 New
21,446 $521,000
Q4 2019

Jul 12, 2023
BUY
$20.78 - $29.99 $445,647 - $643,165
21,446 New
21,446 $598,000
Q3 2019

Jul 12, 2023
BUY
$23.87 - $30.93 $511,916 - $663,324
21,446 New
21,446 $514,000
Q3 2019

Mar 22, 2023
BUY
$23.87 - $30.93 $164,440 - $213,076
6,889 Added 47.32%
21,446 $514,000
Q3 2019

Nov 14, 2019
BUY
$23.87 - $30.93 $164,440 - $213,076
6,889 Added 47.32%
21,446 $515,000
Q2 2019

Jul 12, 2023
BUY
$22.1 - $28.56 $321,709 - $415,747
14,557 New
14,557 $415,000
Q1 2019

Jul 13, 2023
BUY
$12.0 - $25.76 $174,684 - $374,988
14,557 New
14,557 $364,000
Q4 2018

Jul 13, 2023
BUY
$9.15 - $14.85 $133,196 - $216,171
14,557 New
14,557 $183,000
Q4 2018

Mar 22, 2023
SELL
$9.15 - $14.85 $75,350 - $122,289
-8,235 Reduced 36.13%
14,557 $183,000
Q4 2018

Feb 14, 2019
SELL
$9.15 - $14.85 $75,350 - $122,289
-8,235 Reduced 36.13%
14,557 $183,000
Q3 2018

Jul 13, 2023
BUY
$9.55 - $12.64 $139,019 - $184,000
14,557 New
14,557 $139,000
Q3 2018

Mar 22, 2023
SELL
$9.55 - $12.64 $144,758 - $191,597
-15,158 Reduced 39.94%
22,792 $217,000
Q3 2018

Nov 14, 2018
BUY
$9.55 - $12.64 $217,663 - $288,090
22,792 New
22,792 $218,000

Others Institutions Holding VCYT

# of Institutions
338
Shares Held
76.8M
Call Options Held
212K
Put Options Held
18.5K
View Full List

About VERACYTE, INC.

VCYT Quotes by TradingView
  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.19B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email